Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hoofnagle JH, Shafritz DA, Popper H: Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology 1987, 7: 758–763.
Hyams KC: Risks of chronicity following acute hepatitis B virus infection: a review. Clinical Infectious Diseases 1995, 20: 992–1000.
Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR: The serology of chronic hepatitis B infection revisited. Journal of Clinical Investigation 1993, 1: 2586–2595.
Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, Jacobs MJ, Josephson A, Ribot S, Shapiro FL, Stenzel KH, Suki WN, Vyas G: Hepatitis B infection: a point-prevalence study in 15 US hemodialysis centers. Journal of the American Medical Association 1974, 227: 901–906.
Szmuness W, Pick R, Prince AM: The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. American Journal of Epidemiology 1970, 92: 51–61.
Krogsgaard K, Lindhardt BO, Nielson JO, Andersson P, Kryger P, Aldershvile J, Gerstoft J, Pedersen C: The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 1987, 7: 37–41.
Bodswoth NJ, Cooper DA, Donovan B: The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. Journal of Infectious Diseases 1991, 163: 1138–1140.
Luo KX, Zhou R, He C, Liang ZS, Jiang SB: Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. Journal of Medical Virology 1991, 35: 55–59.
Scheitlin T, Grob PJ: Hepatitis and HIV infection in users of illegal drugs. Schweizerische Medizinische Wochenschrift 1992, 122: 1432–1445.
Shih LN, Sheu JC, Wang JT, Huang GT, Chen JS, Sung JL, Wang TH, Chen DS: Detection of hepatitis B viral DNA by polymerase chain reaction in patients with hepatitis B surface antigen. Journal of Medical Virology 1990, 30: 159–162.
Gerken G, Paterlini P, Manns M, Housset C, Terre S, Dienes HP, Hess G, Gerlich WH, Berthelot P, Meyer zum Büschenfelde KH, Brechot C: Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S and S-encoded viral surface antigens. Hepatology 1991, 13: 158–166.
Baker BL, Di-Bisceglie AM, Kaneko S, Miller R, Feinstone SM, Waggoner JG, Hoofnagle JH: Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology 1991, 13: 632–636.
Chemin I, Baginski I, Petit MA, Zoulim F, Pichoud C, Capel F, Hantz O, Trepo C: Correlation between HBV DNA detection by polymerase chain reaction and pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infection. Journal of Medical Virology 1991, 33: 51–57.
Pao CC, Yao DS, Lin CY, Kao SM, Tsao KC, Sun CF, Liaw YF: Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. American Journal of Clinical Pathology 1991, 95: 591–596.
Liang TJ, Bodenheimer HC Jr, Yankee R, Brown NV, Chang K, Huang J, Wands JR: Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. Journal of Medical Virology 1994, 42: 151–157.
Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS: Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. Journal of Infectious Diseases 1991, 163: 397–399.
Jilg W, Sieger E, Zachoval R, Schätzl H: Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 1995, 23: 14–20.
Gross A, Jolle Jemelka HI, Wicki AN, Grob PJ: Hepatitis serological finding “anti-HBc alone”, circulating viral DNA and interpretation of findings. Schweizerische Medizinische Wochenschrift 1993, 123: 1193–1202.
Ledergerber B, von Overbeck J, Egger M, Lüthy R, and the Swiss HIV Cohort Study (SHCS): The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Sozial- und Präventivmedizin 1994, 39: 387–394.
Joller-Jemelka HI, Wicki AN, Grob PJ: Detection of HBs antigen in “anti-HBc alone” positive sera. Journal of Hepatology 1994, 21: 269–272.
Kaneko S, Feinstone SM, Miller R: Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. Journal of Clinical Microbiology 1989, 27: 1930–1933.
Kashala O, Mubikayi L, Kayembe K, Mukeba P, Essex M: Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pres2 antigen is predominantly expressed in HIV infection. Journal of Infectious Diseases 1994, 169: 628–632.
Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and recurrent infection. Hepatology 1995, 21: 1492–1499.
Chung HT, Lai CL, Lok AS: Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995, 22: 25–29.
Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Brechot C: Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. New England Journal of Medicine 1990, 323: 80–85.
Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR: Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991, 13: 1044–1051.
Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P: Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen. New England Journal of Medicine 1985, 312: 270–276.
Lok ASF, Ma OCK: Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma. Hepatology 1990, 12: 582–588.
Gilson RJC, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IVD: Interactions between HIV and hepatitis B virus in homosexual men: effect on the natural history of infection. AIDS 1997, 11: 597–606.
Hoofnagle JH, Seeff IB, Buskell-Bales Z, Zimmerman HJ: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. New England Journal of Medicine 1978, 298: 1379–1383.
Katchaki JN, Brouwer R, Siem TH: Anti-HBc and blood infectivity. New England Journal of Medicine 1978, 298: 1421–1422.
Sugg U, Erhardt S, Schneider W: Chronic low level hepatitis B virus carrier with probable infectivity. Lancet 1982, i: 446–447.
Hopkins R, Kane E, Robertson AE, Haase G: Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc. Medical Laboratory Sciences 1982, 39: 61–62.
Larsen J, Hetland G, Skaug K: Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990, 30: 431–432.
Luo KX, Liang ZS, Yang SC, Zhou R, Meng QH, Zhu YW: Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China. Journal of Medical Virology 1993, 39: 219–223.
Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, Roberts JP, Tomlanovich SJ, Vincenti F, Stock P: The risk of transmission of hepatitis B from HBsAg(−), HBcAB(+), HBlgM(−) organ donors. Transplantation 1995, 59: 230–234.
Descos B, Scotto J, Fayol V, Huet JY, Pichoud C, Hermier M, Ville G, Charvet F, Dargent D, Thoulon JM, Trepo C: Anti-HBc screening for the prevention of perinatal transmission of hepatitis B virus in France. Infection 1987, 15: 434–439.
Dragosics B, Ferenci P, Hitchman E, Denk H: Long-term follow-up study of asymptomatic HbsAg-positive voluntary blood donors in Australia: a clinical and histologic evaluation of 242 cases. Hepatology 1987, 7: 302–306.
Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC: Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991, 13: 627–631.
Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J: The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. American Journal of the Medical Sciences 1979, 277: 17–22.
Lindsay KL, Redeker AG, Aschcavai M: Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1981, 1: 586–589.
Quan CM, Krajden M, Grigoriew GA, Salit IE: Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clinical Infectious Diseases 1993, 17: 117–119.
Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS, 1995, 9: 1131–1136.
Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C: Hepatitis C virus infection in an HIV-positive population in Normandy: antibodies, HCV RNA and genotype prevalence. Journal of Medical Virology 1995, 47: 231–236.
Sanchez-Quijano A, Andreu J, Gavilan F, Luque F, Abad MA, Soto B, Muñoz J, Aznar JM, Leal M, Lissen E: Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 949–953.